US Patent 9221843 Heteroaryl inhibitors of PDE4

Patent 9221843 was granted and assigned to Tetra Therapeutics on December, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Tetra Therapeutics

Current Assignee

Tetra Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

92218430

Date of Patent

December 29, 2015

Patent Application Number

143496880

Date Filed

October 24, 2013

Patent Citations Received

‌

US Patent 11767334 Heteroaryl inhibitors of PDE4

Patent Primary Examiner

‌

Deepak Rao

Patent abstract

The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9221843 Heteroaryl inhibitors of PDE4

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API